Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (1999);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.602;Q1;210;18;66;290;1399;66;20.7;16.11;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;7.884;Q1;241;19;57;8938;935;57;15.39;470.42;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;21100456838;Cell Chemical Biology;journal;24519448, 24519456;4.693;Q1;190;128;342;5031;2053;317;6;39.3;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
4;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.514;Q1;225;102;304;4699;2317;233;8.2;46.07;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
5;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;3.271;Q1;66;31;22;5954;143;22;8.2;192.06;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
6;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;2.964;Q1;211;73;148;11003;1042;148;7.67;150.73;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.961;Q1;202;292;880;10710;4859;880;5.37;36.68;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.634;Q1;227;176;309;8662;1624;291;4.69;49.22;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.632;Q1;146;137;315;5701;1288;291;3.32;41.61;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
10;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;2.527;-;144;91;201;3302;1174;197;4.28;36.29;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
11;26371;Natural Product Reports;journal;02650568, 14604752;2.402;Q1;188;42;96;6961;435;96;4.5;165.74;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
12;82448;Mutation Research - DNA Repair;journal;09218777;2.292;Q1;75;64;210;3172;656;210;3.01;49.56;Netherlands;Western Europe;Elsevier BV;1989-2001;"Genetics (Q1); Molecular Biology (Q1); Toxicology (Q1)"
13;20435;Neuropharmacology;journal;00283908, 18737064;2.249;Q1;176;182;563;8527;2242;556;4.05;46.85;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
14;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.039;Q1;117;13;53;2887;295;52;4.58;222.08;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
15;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;2.019;Q1;78;117;332;2065;757;283;2.42;17.65;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
16;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;1.884;Q1;269;599;1823;17049;7369;1714;4.08;28.46;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
17;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.809;Q1;276;563;1667;23161;6981;1623;4.27;41.14;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
18;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;1.724;Q1;233;227;449;21816;1104;447;2.92;96.11;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Cell Biology (Q2); Cellular and Molecular Neuroscience (Q2); Molecular Biology (Q2)"
19;21782;Psychopharmacology;journal;00333158, 14322072;1.687;Q1;202;393;935;16557;3330;907;3.02;42.13;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
20;98666;Mutation Research - Reviews in Genetic Toxicology;journal;01651110;1.653;Q1;26;0;38;0;202;38;0;0;Netherlands;Western Europe;Elsevier BV;1975-1996;"Genetics (Q1); Toxicology (Q1)"
21;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.651;Q1;70;68;174;1138;541;168;3.44;16.74;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
22;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;1.624;Q1;85;190;534;7166;1373;534;2.56;37.72;United States;Northern America;Wiley-Blackwell;1918-2021;"Biochemistry (Q1); Drug Discovery (Q1); Inorganic Chemistry (Q1); Organic Chemistry (Q1); Physical and Theoretical Chemistry (Q1); Catalysis (Q2)"
23;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.612;Q1;223;709;2245;26927;7684;2244;3.26;37.98;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
24;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.586;Q1;169;81;186;5697;1014;178;5.21;70.33;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;18148;Pain;journal;18726623, 03043959;1.566;Q1;269;280;758;11500;2923;648;3.5;41.07;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
26;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.563;Q1;72;38;159;783;477;158;3.53;20.61;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Immunology (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Microbiology (medical) (Q1); Pharmacology (Q1)"
27;19907;Medicinal Research Reviews;journal;01986325, 10981128;1.562;Q1;134;34;61;2700;243;61;2.68;79.41;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
28;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.537;Q1;163;165;566;6471;1912;562;3.37;39.22;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
29;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.527;Q1;233;751;2170;27531;7697;2170;3.4;36.66;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
30;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.523;Q1;81;68;15;3096;67;15;4.47;45.53;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.479;Q1;177;152;326;4644;1092;326;3.43;30.55;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
32;26514;Tetrahedron Letters;journal;00404039, 18733581;1.461;Q1;173;2399;7584;47053;17397;7583;2.43;19.61;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
33;19427;Advances in Pharmacology;journal;15578925, 10543589;1.389;Q1;78;17;378;3069;985;368;2.04;180.53;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
34;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.38;Q1;76;12;30;1994;157;30;5.42;166.17;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
35;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.34;Q1;97;49;94;1950;278;93;2.79;39.8;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
36;26795;Controlled Clinical Trials;journal;01972456;1.339;Q1;74;48;169;1042;290;151;1.33;21.71;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
37;26512;Tetrahedron;journal;14645416, 00404020;1.333;Q1;226;1153;3787;42360;8132;3780;2.17;36.74;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
38;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.329;Q1;213;295;924;6991;2462;893;2.51;23.7;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
39;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.309;Q1;129;125;245;4410;594;222;2.48;35.28;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
40;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.286;Q1;166;70;103;6965;293;102;2.41;99.5;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
41;23053;Journal of Natural Products;journal;01633864, 15206025;1.207;Q1;147;443;1026;7710;1851;1026;1.81;17.4;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
42;29682;Receptors and Channels;journal;10606823;1.182;Q1;42;21;78;923;148;78;1.65;43.95;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q1); Endocrinology (Q1); Pharmacology (Q1); Cell Biology (Q2)"
43;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.178;Q1;206;395;1293;16339;3522;1223;2.67;41.36;United States;Northern America;Elsevier Inc.;1958-2021;"Pharmacology (Q1); Biochemistry (Q2)"
44;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.154;Q1;186;208;762;6063;1756;761;2.32;29.15;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
45;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.113;Q1;104;44;152;1747;411;152;2.56;39.7;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q1)"
46;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.111;Q1;203;368;1077;7250;2914;842;2.71;19.7;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
47;19425;Advances in Drug Research;journal;00652490;1.109;Q1;11;0;16;0;42;16;2.78;0;United States;Northern America;Academic Press Inc.;1964-1965, 1967, 1970-1971, 1973-1975, 1977, 1989-1997;Pharmacology (Q1)
48;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.103;Q1;96;57;103;1574;176;100;1.16;27.61;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
49;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.051;Q1;115;136;433;4850;589;432;1.28;35.66;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
50;23010;Journal of Controlled Release;journal;18734995, 01683659;1.036;Q1;282;207;565;5332;1283;559;2.17;25.76;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
51;23916;Environmental Pollution;journal;02697491, 18736424;1.028;Q1;249;167;607;6619;799;604;1.16;39.63;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
52;12000154522;Advances in Antiviral Drug Design;book series;10758593;1.023;Q1;12;7;7;519;23;5;0;74.14;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Infectious Diseases (Q1); Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Virology (Q2)"
53;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.004;Q1;175;234;787;10010;2063;776;2.59;42.78;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
54;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1;Q1;182;228;607;6767;1660;600;2.57;29.68;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
55;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;0.978;Q1;331;102;348;9151;868;326;2.15;89.72;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
56;21196;Drug Discovery Today;journal;18785832, 13596446;0.973;Q1;185;124;224;2447;540;208;2.02;19.73;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
57;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.957;Q1;83;87;244;3049;442;237;1.75;35.05;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
58;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.956;Q1;93;166;606;5842;1323;605;2.03;35.19;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
59;21333;European Journal of Pharmacology;journal;00142999, 18790712;0.953;Q1;189;908;2899;32018;6282;2899;2.05;35.26;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
60;23109;Journal of Psychopharmacology;journal;14617285, 02698811;0.948;Q1;121;83;210;2474;450;200;2.65;29.81;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
61;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.926;Q1;79;46;96;468;144;94;1.37;10.17;United States;Northern America;SAGE Publications Inc.;1996-2017;"Biotechnology (Q1); Drug Discovery (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Molecular Medicine (Q2)"
62;21744;Planta Medica;journal;14390221, 00320943;0.912;Q1;122;240;613;3855;741;566;1.14;16.06;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Molecular Medicine (Q2)"
63;26380;Drug and Alcohol Dependence;journal;03768716;0.888;Q1;173;109;321;4438;656;316;2.09;40.72;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
64;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.875;Q1;154;677;1945;13396;3480;1944;1.87;19.79;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
65;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;0.867;Q1;159;319;1006;12144;2078;987;1.92;38.07;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
66;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.864;Q1;171;321;688;11263;1245;687;1.78;35.09;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
67;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;0.863;Q1;195;510;831;4133;1682;794;1.57;8.1;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
68;4000150314;Chemical Biology and Drug Design;journal;17470277;0.862;-;82;143;245;4445;417;243;1.7;31.08;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q2)"
69;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.861;Q1;66;41;58;1125;171;58;1.83;27.44;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
70;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;0.861;Q1;139;298;1043;12568;1976;1040;1.86;42.17;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
71;25075;Ecotoxicology;journal;09639292, 15733017;0.859;Q1;97;40;88;1581;113;87;1.05;39.53;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
72;15840;Journal of Antibiotics;journal;00218820, 18811469;0.858;Q1;84;163;619;2320;682;573;1.07;14.23;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
73;12584;Drug Metabolism Reviews;journal;10979883, 03602532;0.855;Q1;100;45;99;2883;265;99;3.29;64.07;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
74;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;0.851;Q1;183;69;71;7616;176;71;3.15;110.38;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
75;23412;Journal of AOAC International;journal;10603271;0.844;Q1;90;193;502;4191;679;502;1.33;21.72;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q1); Food Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2)"
76;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.842;Q2;95;363;1235;7001;1444;1235;1.16;19.29;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2)"
77;16067;Reading Teacher;journal;00340561;0.842;Q1;53;62;154;1444;90;154;0.49;23.29;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
78;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.829;Q2;66;30;16;1446;27;16;1.69;48.2;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
79;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0.827;Q1;153;237;645;6020;1455;596;2.33;25.4;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
80;14805;Steroids;journal;0039128X, 18785867;0.827;Q1;107;109;322;3538;725;320;2.5;32.46;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
81;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.82;Q1;64;32;108;792;202;103;1.12;24.75;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q1)
82;24763;Addictive Behaviors;journal;03064603;0.811;Q1;135;90;254;2333;361;254;1.07;25.92;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
83;37409;Anti-Cancer Drug Design;journal;02669536;0.802;Q1;53;53;155;2342;347;152;2.5;44.19;United States;Northern America;Cognizant Communication Corporation;1985-2001;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Oncology (Q1); Pharmacology (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
84;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.802;Q1;102;65;324;1427;387;321;1.02;21.95;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
85;21237;Drug Safety;journal;01145916, 11791942;0.795;Q1;131;92;208;6358;597;202;2.83;69.11;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
86;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;0.794;Q1;33;17;61;623;140;59;2.51;36.65;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2)"
87;19700180810;Alkaloids: Chemical and Biological Perspectives;book series;07358210;0.772;Q2;14;11;22;2316;26;10;0.78;210.55;Netherlands;Western Europe;Elsevier;1996, 1998-1999, 2001;"Drug Discovery (Q2); Organic Chemistry (Q2)"
88;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;0.753;Q1;118;113;259;3632;462;256;2.88;32.14;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2); Neurology (Q2)"
89;110172;Progress in Drug Research;book series;0071786X;0.725;Q1;44;11;45;1760;81;43;2.03;160;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
90;22477;Investigational New Drugs;journal;01676997, 15730646;0.72;Q1;90;38;143;2490;301;142;2.01;65.53;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;22319;Toxicon;journal;18793150, 00410101;0.72;Q1;133;145;509;3960;703;503;1.23;27.31;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q1)
92;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;0.719;Q1;95;53;143;2565;240;143;1.43;48.4;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q2)"
93;36881;Journal of Lipid Mediators and Cell Signalling;journal;09297855;0.717;Q1;22;0;119;0;147;119;0.93;0;Netherlands;Western Europe;Elsevier BV;1949, 1994-1997;"Pharmacology (Q1); Immunology (Q2)"
94;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.71;Q1;87;120;518;4841;760;516;1.41;40.34;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2); Physiology (medical) (Q2)"
95;16948;Chirality;journal;1520636X, 08990042;0.707;Q1;80;124;307;2883;462;303;1.36;23.25;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Pharmacology (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3)"
96;20473;Life Sciences;journal;18790631, 00243205;0.706;Q1;174;672;1877;21440;3433;1877;1.71;31.9;United States;Northern America;Elsevier Inc.;1962-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
97;19617;Antiviral Research;journal;01663542, 18729096;0.703;Q1;134;70;217;3183;441;216;1.98;45.47;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
98;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.702;Q1;90;49;147;1824;168;147;1.17;37.22;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Pharmacology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2)"
99;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;0.7;Q1;115;48;130;2463;202;130;1.44;51.31;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Clinical Biochemistry (Q2); Cell Biology (Q3)"
100;19900192900;Molecular Informatics;journal;18681751, 18681743;0.697;Q2;70;31;115;917;236;113;1.58;29.58;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
101;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.672;Q1;80;65;197;2155;419;187;1.91;33.15;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Neurology (clinical) (Q2)"
102;25934;Cytokines, Cellular and Molecular Therapy;journal;14660830, 13684736;0.67;Q1;27;26;56;1337;101;55;1.8;51.42;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2000, 2002;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
103;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.666;Q1;95;49;134;1592;227;125;1.3;32.49;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
104;55157;Perspectives in Drug Discovery and Design;journal;15739023, 09282866;0.664;Q1;38;26;81;1715;155;81;2.04;65.96;Netherlands;Western Europe;Kluwer Academic Publishers;1993-2000;"Pharmacology (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
105;80381;Tumor Targeting;journal;13518488;0.664;Q1;10;32;22;1183;41;21;1.86;36.97;United Kingdom;Western Europe;Stockton Press;1998-1999;"Pharmacology (Q1); Cancer Research (Q2)"
106;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.663;Q1;51;224;687;4475;739;687;1.12;19.98;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Biochemistry (Q3)"
107;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.66;Q1;64;75;214;1690;320;203;1.47;22.53;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Health, Toxicology and Mutagenesis (Q2)"
108;22375;Indian Drugs;journal;0019462X;0.66;Q1;31;157;412;2354;229;392;0.58;14.99;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1); Drug Discovery (Q2)"
109;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.66;Q1;96;105;372;2061;541;352;1.36;19.63;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
110;25093;Environmental Toxicology;journal;15227278, 15204081;0.658;Q1;81;61;112;1754;111;111;0.92;28.75;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Health, Toxicology and Mutagenesis (Q2)"
111;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.657;Q1;36;7;20;1411;37;12;1.25;201.57;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q3)"
112;18966;Mutagenesis;journal;02678357, 14643804;0.655;Q1;95;89;267;3251;549;264;1.9;36.53;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Toxicology (Q1); Genetics (clinical) (Q2); Health, Toxicology and Mutagenesis (Q2); Genetics (Q3)"
113;21192;Drug Development Research;journal;02724391, 10982299;0.654;Q2;62;80;265;3269;417;263;1.14;40.86;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q2)
114;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.648;Q2;104;290;1023;9704;1607;1016;1.48;33.46;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
115;12611;Drug Resistance Updates;journal;13687646, 15322084;0.642;Q2;119;51;56;3305;109;48;1.95;64.8;United States;Northern America;Churchill Livingstone;1998-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Infectious Diseases (Q2); Oncology (Q2); Pharmacology (Q2)"
116;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.638;Q1;81;60;169;1066;201;167;0.98;17.77;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
117;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.637;Q1;133;341;835;7075;953;835;1.18;20.75;Netherlands;Western Europe;Elsevier;1983-2022;"Pharmaceutical Science (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2); Analytical Chemistry (Q3); Spectroscopy (Q3)"
118;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.636;Q1;114;163;469;4403;841;466;1.79;27.01;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
119;24652;Chemico-Biological Interactions;journal;00092797;0.635;Q1;128;147;296;4005;540;294;1.87;27.24;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
120;40442;Journal of Toxicology and Environmental Health;journal;00984108;0.633;Q2;42;0;196;0;338;196;1.86;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1975-1998, 2000;"Pollution (Q2); Toxicology (Q2)"
121;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;0.632;Q2;134;96;275;3693;397;274;1.49;38.47;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q2); Biological Psychiatry (Q3)"
122;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.624;Q2;62;55;234;1416;223;233;0.81;25.75;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
123;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.623;Q2;76;219;829;3757;628;829;0.7;17.16;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pollution (Q2); Toxicology (Q2)"
124;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.62;Q1;39;36;106;1069;95;102;0.77;29.69;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Health Policy (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1); Public Health, Environmental and Occupational Health (Q1)"
125;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;0.616;Q1;229;404;1275;9373;1485;1269;1.03;23.2;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
126;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.612;Q2;98;97;367;2773;393;265;1.07;28.59;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
127;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.611;Q2;121;157;461;4251;818;447;1.77;27.08;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
128;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;0.608;Q2;89;12;14;900;30;14;2.14;75;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
129;20634;Journal of Texture Studies;journal;00224901, 17454603;0.597;Q1;57;38;126;859;106;126;0.86;22.61;United States;Northern America;Wiley-Blackwell;1969-2021;"Pharmaceutical Science (Q1); Food Science (Q2)"
130;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.595;Q2;114;137;550;3310;922;510;1.62;24.16;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
131;23942;Biomedical Chromatography;journal;10990801, 02693879;0.593;Q2;68;126;252;2064;267;250;0.96;16.38;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Molecular Biology (Q3)"
132;25864;Heterocycles;journal;03855414;0.591;Q2;66;394;1177;10151;1145;1176;1.06;25.76;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Organic Chemistry (Q2); Pharmacology (Q2); Analytical Chemistry (Q3)"
133;24604;Archives of Toxicology;journal;14320738, 03405761;0.59;Q2;121;72;328;2439;493;325;1.33;33.88;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
134;38865;Natural Toxins;journal;10569014;0.588;Q2;47;56;113;1661;157;110;0.89;29.66;United States;Northern America;"John Wiley &amp; Sons Inc.";1992-1999;Toxicology (Q2)
135;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.586;Q2;103;73;210;3058;338;196;1.59;41.89;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Developmental Neuroscience (Q3); Cellular and Molecular Neuroscience (Q4)"
136;29053;Molecular Diversity;journal;1573501X, 13811991;0.584;Q2;58;0;104;0;169;104;1.73;0;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Organic Chemistry (Q2); Catalysis (Q3); Inorganic Chemistry (Q3); Molecular Biology (Q3); Physical and Theoretical Chemistry (Q3)"
137;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.58;Q2;107;209;626;7197;887;625;1.27;34.44;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q3)"
138;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.578;Q2;64;59;170;1447;169;169;0.87;24.53;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Pharmacology (medical) (Q1); Ophthalmology (Q2); Pharmacology (Q2)"
139;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.573;Q2;74;72;205;2542;263;204;1.2;35.31;United States;Northern America;Wiley-Blackwell;1986-2021;"Medicine (miscellaneous) (Q1); Process Chemistry and Technology (Q1); Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
140;24785;Alcohol;journal;07418329;0.569;Q2;83;100;271;4123;406;268;1.43;41.23;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Neurology (Q2); Toxicology (Q2); Biochemistry (Q3); Behavioral Neuroscience (Q4)"
141;68602;Immunopharmacology;journal;01623109;0.565;Q2;68;168;347;4295;522;344;1.46;25.57;Netherlands;Western Europe;Elsevier BV;1978-2000;Pharmacology (Q2)
142;25214;Toxicologic Pathology;journal;15331601, 01926233;0.553;Q2;112;108;360;3036;393;322;1.04;28.11;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
143;29712;Clinical Therapeutics;journal;1879114X, 01492918;0.55;Q2;140;187;406;5437;744;357;1.92;29.07;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
144;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.544;Q1;32;0;11;0;37;11;3.36;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
145;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.542;Q1;20;32;79;430;58;79;0.65;13.44;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q1); Pharmaceutical Science (Q1)"
146;33577;Polymer Gels and Networks;journal;09667822;0.538;Q1;29;0;107;0;80;106;0.78;0;United Kingdom;Western Europe;Pergamon Press Ltd.;1993-1998;"Chemical Engineering (miscellaneous) (Q1); Pharmaceutical Science (Q1); Polymers and Plastics (Q1)"
147;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.535;Q2;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
148;22410;Inflammation Research;journal;1420908X, 10233830;0.534;Q2;94;169;455;4310;642;449;1.33;25.5;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
149;14822;Xenobiotica;journal;00498254, 13665928;0.534;Q2;82;93;297;3240;478;296;1.42;34.84;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
150;21165;PharmacoEconomics;journal;11707690, 11792027;0.533;Q2;104;134;437;5226;626;403;1.42;39;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q2); Public Health, Environmental and Occupational Health (Q2)"
151;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.53;Q2;71;58;286;1868;335;255;1.02;32.21;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
152;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.518;Q1;40;55;176;766;93;151;0.49;13.93;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q1)
153;22378;Vascular Pharmacology;journal;18793649, 15371891;0.518;Q2;100;163;749;5521;894;746;1.17;33.87;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Molecular Medicine (Q3); Physiology (Q3)"
154;25898;Journal of Peptide Science;journal;10752617, 10991387;0.517;Q2;68;58;128;2119;150;128;1.26;36.53;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q4)"
155;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.515;Q2;175;107;306;3103;398;297;1.17;29;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
156;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.513;Q2;50;38;83;1154;61;83;0.69;30.37;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q3)"
157;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.511;Q2;112;90;287;2401;326;257;1.2;26.68;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
158;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.51;Q2;93;106;347;3874;427;344;1.11;36.55;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
159;25219;Toxicology;journal;0300483X, 18793185;0.507;Q2;165;135;584;5201;884;583;1.37;38.53;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q2)
160;16533;Phytochemical Analysis;journal;09580344, 10991565;0.499;Q2;76;52;137;1137;124;137;0.76;21.87;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Food Science (Q2); Plant Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Molecular Medicine (Q3)"
161;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.497;Q2;54;32;176;1616;306;175;1.79;50.5;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
162;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.496;Q2;96;127;418;3493;725;410;1.83;27.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
163;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.493;Q2;183;130;380;4609;558;372;1.3;35.45;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Medicine (miscellaneous) (Q1); Food Science (Q2); Toxicology (Q2)"
164;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;0.492;Q1;168;69;210;1471;198;204;0.74;21.32;Netherlands;Western Europe;Elsevier;1991-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Biotechnology (Q2)"
165;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.491;Q2;39;34;97;270;39;97;0.47;7.94;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2)"
166;37773;Cytokines and Molecular Therapy;journal;13556568;0.49;Q2;14;0;31;0;49;31;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-1996;"Immunology and Allergy (Q2); Pharmacology (Q2)"
167;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.483;Q2;92;114;168;3961;282;165;1.26;34.75;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
168;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.48;Q2;103;100;259;3638;385;244;1.27;36.38;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
169;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.477;Q2;52;42;127;705;61;122;0.5;16.79;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
170;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.475;Q2;41;0;39;0;21;33;0.5;0;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q2); Organic Chemistry (Q3)"
171;24071;Metal-Based Drugs;journal;07930291, 16875486;0.474;Q2;38;47;106;1303;110;105;1.03;27.72;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Pharmacology (Q2); Toxicology (Q2); Drug Discovery (Q3); Inorganic Chemistry (Q3)"
172;31756;Mutation Research - Environmental Mutagenesis and Related Subjects Including Methodology;journal;01651161;0.472;Q2;27;0;67;0;112;67;0;0;Netherlands;Western Europe;Elsevier BV;1973, 1975-1996;"Toxicology (Q2); Genetics (Q3)"
173;33349;Japanese Journal of Pharmacology;journal;13473506, 00215198;0.471;Q2;62;185;457;5397;498;457;1.08;29.17;Japan;Asiatic Region;Japanese Pharmacological Society;1951-2002;Pharmacology (Q2)
174;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.468;Q1;62;73;172;1196;122;152;0.67;16.38;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
175;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.464;Q2;113;122;414;4218;417;410;0.89;34.57;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Physiology (Q3)"
176;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.463;Q2;64;42;126;1602;164;126;1.51;38.14;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Toxicology (Q2); Cell Biology (Q3); Health, Toxicology and Mutagenesis (Q3)"
177;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.462;Q2;62;44;82;676;89;82;0.9;15.36;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Molecular Medicine (Q3); Molecular Biology (Q4)"
178;24028;Reproductive Toxicology;journal;08906238, 18731708;0.462;Q2;117;68;235;2369;280;224;1.06;34.84;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
179;17067;Phytomedicine;journal;09447113, 1618095X;0.461;Q1;127;58;156;1070;143;156;0.7;18.45;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
180;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.46;Q1;50;53;142;1310;155;140;1.12;24.72;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
181;20104;CNS Drug Reviews;journal;1080563X, 15273458;0.457;Q2;61;48;74;1513;86;74;0.69;31.52;United States;Northern America;Neva Press, Inc.;1995-2007;"Pharmacology (Q2); Neuropsychology and Physiological Psychology (Q3)"
182;18077;Fitoterapia;journal;0367326X, 18736971;0.455;Q2;110;143;392;1503;151;392;0.35;10.51;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Drug Discovery (Q3)"
183;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.452;Q2;21;0;0;0;0;0;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q2)
184;86329;Mutation Research - Mutation Research Genomics;journal;13835726, 18731341;0.447;Q2;20;9;21;285;22;20;1.05;31.67;Netherlands;Western Europe;Elsevier BV;1997-2001;"Toxicology (Q2); Genetics (Q3)"
185;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.444;Q3;66;36;97;1354;90;92;0.68;37.61;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Biology (Q4)"
186;31755;Mutation Research - Genetic Toxicology Testing and Biomonitoring of Environmental or Occupational Exposure;journal;01651218;0.429;Q2;38;0;146;0;263;146;0;0;Netherlands;Western Europe;Elsevier BV;1973-1976, 1978-1996;"Toxicology (Q2); Genetics (Q3)"
187;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.426;Q2;90;172;463;2835;284;461;0.63;16.48;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Pharmacology (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
188;25109;Inhalation Toxicology;journal;08958378, 10917691;0.426;Q3;90;69;173;2281;189;172;0.9;33.06;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
189;20570;Chemotherapy;journal;00093157, 14219794;0.424;Q2;58;84;227;2084;239;226;0.94;24.81;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q1); Infectious Diseases (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3)"
190;24749;Addiction Biology;journal;13556215, 13691600;0.421;Q2;83;47;119;1993;128;117;1.14;42.4;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
191;23489;Chemical Speciation and Bioavailability;journal;09542299;0.421;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
192;21194;Pharmacology;journal;00317012, 14230313;0.419;Q2;60;71;249;2126;264;247;1.02;29.94;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
193;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.418;Q1;122;302;926;6996;861;926;0.86;23.17;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
194;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.413;Q3;61;76;150;2170;189;144;1.08;28.55;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medicine (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Toxicology (Q3)"
195;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.41;Q2;205;199;376;4745;325;374;0.74;23.84;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Pharmacology (Q2); Drug Discovery (Q3)"
196;18073;NeuroToxicology;journal;18729711, 0161813X;0.409;Q3;122;86;273;3438;299;266;1.01;39.98;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q3); Toxicology (Q3)"
197;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.408;Q2;61;61;212;1339;225;208;1.05;21.95;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
198;25189;Reviews in Toxicology;journal;13826980;0.404;Q3;20;8;58;1071;51;57;0.88;133.88;Netherlands;Western Europe;IOS Press BV;1997-1999, 2001;Toxicology (Q3)
199;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.401;Q3;91;79;205;2204;225;205;1.24;27.9;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q3)
200;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.4;Q2;20;55;169;0;163;165;1.11;0;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
201;16573;Phytotherapy Research;journal;10991573, 0951418X;0.397;Q2;140;160;625;2854;270;622;0.36;17.84;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
202;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.394;Q2;77;69;267;2303;258;265;0.84;33.38;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
203;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.394;Q2;81;76;227;2791;273;227;1.12;36.72;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3)"
204;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.39;Q2;144;104;130;2460;131;128;0.94;23.65;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q2)
205;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.384;Q2;65;75;220;1505;190;220;0.81;20.07;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
206;21186;Drug Design and Discovery;journal;10559612, 10292322;0.384;Q3;20;21;57;607;51;56;0.81;28.9;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q3)"
207;25224;Toxicology in Vitro;journal;18793177, 08872333;0.382;Q3;112;109;261;2529;288;259;1.08;23.2;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
208;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.38;Q2;39;105;378;2389;332;378;0.85;22.75;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
209;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.376;Q3;62;73;158;4477;177;157;1.2;61.33;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
210;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.37;Q2;69;86;347;2053;319;333;0.86;23.87;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
211;24578;Mathematical Medicine and Biology;journal;14778599;0.368;Q2;46;18;59;531;45;59;0.88;29.5;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
212;68818;International Journal of Geriatric Psychopharmacology;journal;13648233;0.365;Q1;11;11;53;297;65;50;1.23;27;United Kingdom;Western Europe;Stockton Press;1997-2000;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Geriatrics and Gerontology (Q2); Pharmacology (medical) (Q2); Neuropsychology and Physiological Psychology (Q3)"
213;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.365;Q2;124;502;992;6285;845;964;0.75;12.52;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
214;36479;International Journal of Immunopharmacology;journal;01920561;0.364;Q2;50;95;237;2473;230;237;0.83;26.03;Netherlands;Western Europe;Elsevier BV;1979-2000;"Pharmacology (Q2); Immunology (Q3)"
215;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.362;Q2;75;58;185;1582;157;184;0.88;27.28;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q3)"
216;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.36;Q3;48;454;356;4222;299;354;0.81;9.3;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Radiology, Nuclear Medicine and Imaging (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Spectroscopy (Q3)"
217;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.356;Q2;77;143;398;6018;323;394;1.02;42.08;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
218;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.352;Q2;38;0;48;0;41;48;0;0;United States;Northern America;Old City Publishing;1996, 2002-2020;"Pharmacology (Q2); Cancer Research (Q3); Drug Discovery (Q3)"
219;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.351;Q2;61;74;257;1251;55;257;0.16;16.91;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
220;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;0.348;Q2;109;155;426;12075;435;418;1.06;77.9;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
221;25240;Toxicology Letters;journal;03784274, 18793169;0.346;Q3;150;210;614;6246;546;607;0.76;29.74;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
222;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.343;Q2;53;51;115;1749;103;115;0.81;34.29;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3); Toxicology (Q3)"
223;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.343;Q2;79;33;119;1167;129;119;1.42;35.36;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
224;57765;Journal of Serotonin Research;journal;13507702;0.341;Q2;8;0;43;0;30;43;0.45;0;Netherlands;Western Europe;Koninklijke Nederlandse Maatschappij voor Diergeneeskunde;1994-1998;"Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
225;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.34;Q2;52;32;114;1171;61;106;0.58;36.59;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
226;23055;Journal of Natural Toxins;journal;10588108;0.34;Q3;26;35;76;1571;61;76;0.71;44.89;United States;Northern America;Alaken Inc.;1996-2002;"Environmental Science (miscellaneous) (Q1); Toxicology (Q3)"
227;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.334;Q2;66;37;80;642;56;80;0.64;17.35;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
228;25218;Toxicological Sciences;journal;10960929, 10966080;0.332;Q3;193;212;482;8424;862;477;1.56;39.74;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q3)
229;23039;Journal of Liposome Research;journal;08982104, 15322394;0.331;Q2;53;41;122;1331;108;115;0.79;32.46;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
230;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.33;Q2;76;59;68;1992;66;67;0.85;33.76;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q2); Physiology (Q3); Biochemistry (Q4); Cell Biology (Q4)"
231;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.329;Q2;52;71;189;2599;134;189;0.52;36.61;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
232;16117;Pharmaceutical Biotechnology;journal;10780467;0.329;Q2;27;17;71;1820;61;71;0.84;107.06;United States;Northern America;Kluwer/Plenum Publishers;1993, 1995-1999, 2002;"Pharmaceutical Science (Q2); Applied Microbiology and Biotechnology (Q3)"
233;25106;Human and Experimental Toxicology;journal;09603271;0.328;Q3;82;107;413;2848;361;399;0.84;26.62;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
234;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;0.324;Q2;113;40;26;1850;20;26;0.77;46.25;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q3)"
235;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.323;Q3;52;0;0;0;0;0;0;0;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
236;52649;Pharmaceutical and Pharmacological Letters;journal;09399488;0.319;Q2;17;23;150;370;83;150;0.41;16.09;Germany;Western Europe;Stuttgart Medpharm Scientific Publishers;1996-2001;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
237;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.315;Q3;50;18;42;292;44;42;0.86;16.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
238;20770;Drug Delivery;journal;10717544, 15210464;0.314;Q2;72;31;110;866;76;110;0.64;27.94;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
239;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.314;Q2;73;31;133;606;89;129;0.65;19.55;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
240;73430;Pharmaceutical Technology;journal;15432521;0.313;Q2;38;100;269;801;83;258;0.28;8.01;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
241;21100470510;Drug Research;journal;21949379, 21949387;0.311;Q3;65;166;697;3395;557;692;0.66;20.45;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
242;21102;Pharmaceutical Journal;journal;00316873;0.31;Q2;28;439;957;1954;158;516;0.15;4.45;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
243;73138;Journal of Drug Development and Clinical Practice;journal;13579215;0.309;Q2;8;0;39;0;37;35;0;0;United Kingdom;Western Europe;Gardiner-Caldwell Communications Ltd.;1995-1996;Pharmacology (Q2)
244;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.308;Q2;88;40;246;1383;170;246;0.63;34.58;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
245;21169;Pharmacological Research;journal;10436618, 10961186;0.308;Q2;147;147;450;4946;364;447;0.75;33.65;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
246;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.307;Q2;52;103;284;2600;250;276;0.82;25.24;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3)"
247;110097;Food and Drug Law Journal;journal;1064590X;0.306;Q2;22;48;155;4007;59;155;0.45;83.48;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Public Health, Environmental and Occupational Health (Q2)"
248;67483;Archives Internationales de Pharmacodynamie et de Therapie;journal;00039780;0.303;Q2;10;0;23;0;26;23;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1946-1996;Pharmacology (Q2)
249;21790;Antiviral Therapy;journal;20402058, 13596535;0.3;Q3;89;55;177;390;99;159;0.54;7.09;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Pharmacology (medical) (Q2); Infectious Diseases (Q3); Pharmacology (Q3)"
250;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.3;Q2;50;28;68;1342;52;68;0.96;47.93;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
251;27210;In Vivo;journal;17917549, 0258851X;0.296;Q3;64;90;258;3341;204;257;0.88;37.12;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
252;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.295;Q2;91;206;651;6310;414;650;0.56;30.63;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Biochemistry (Q4); Cell Biology (Q4); Physiology (Q4)"
253;21717;Die Pharmazie;journal;00317144;0.292;Q2;66;235;784;4606;422;783;0.53;19.6;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
254;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.29;Q3;109;74;231;3319;170;201;0.79;44.85;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
255;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.29;Q3;70;89;211;2076;145;211;0.64;23.33;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
256;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.282;Q2;48;325;633;5342;234;633;0.33;16.44;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
257;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.28;Q3;63;58;159;1859;106;141;0.76;32.05;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
258;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.28;Q3;39;51;189;1139;127;186;0.5;22.33;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
259;13671;Biologicals;journal;10958320, 10451056;0.278;Q3;60;61;157;769;120;153;0.78;12.61;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
260;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.277;Q3;99;494;1380;5867;699;883;0.53;11.88;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
261;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.277;Q2;63;55;125;1505;111;118;0.84;27.36;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
262;54408;Pharmacy and Pharmacology Communications;journal;14608081;0.273;Q2;25;130;122;2056;67;120;0.55;15.82;United Kingdom;Western Europe;Pharmaceutical Press;1993, 1995, 1998-2000;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
263;25245;Veterinary and Human Toxicology;journal;01456296;0.27;Q3;41;104;302;1877;166;294;0.5;18.05;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Veterinary (miscellaneous) (Q3)"
264;4400151608;ChemMedChem;journal;18607187, 18607179;0.269;Q2;106;124;352;3203;201;351;0.46;25.83;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q3); Organic Chemistry (Q4)"
265;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.264;Q3;51;20;43;1380;34;42;0.79;69;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
266;22365;International Antiviral News;journal;09652310;0.264;Q3;8;27;109;367;45;84;0.39;13.59;United Kingdom;Western Europe;International Medical Press Ltd;1994-2001;"Pharmacology (Q3); Virology (Q4)"
267;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.262;Q3;42;77;315;1420;167;296;0.59;18.44;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
268;80418;Pharmaceutical Sciences;journal;13566881;0.259;Q2;20;0;270;0;143;269;0.59;0;United Kingdom;Western Europe;Royal Pharmaceutical Society of Great Britain;1996-1997;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
269;25171;Mycotoxin Research;journal;18671632, 01787888;0.258;Q3;40;11;35;244;13;35;0.43;22.18;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Microbiology (Q3); Toxicology (Q3)"
270;36497;Pharmaceutica Acta Helvetiae;journal;00316865;0.257;Q2;40;23;136;518;86;136;0.58;22.52;Netherlands;Western Europe;Elsevier BV;1945-2000;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
271;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.253;Q3;38;74;347;1645;156;347;0.45;22.23;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Bioengineering (Q3); Drug Discovery (Q3); Analytical Chemistry (Q4); Biochemistry (Q4); Molecular Medicine (Q4)"
272;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.251;Q2;50;87;280;883;68;264;0.21;10.15;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q4)"
273;78667;Pharmacology Communications;journal;10604456;0.251;Q3;8;0;119;0;50;119;0.36;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-1997;Pharmacology (Q3)
274;34232;Toxicology Methods;journal;10517235;0.248;Q3;18;25;67;482;37;67;0.67;19.28;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2001;Toxicology (Q3)
275;79053;Natural Product Sciences;journal;12263907;0.245;Q4;28;37;71;663;15;71;0.21;17.92;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
276;32946;Developments in Biological Standardization;journal;03015149;0.243;Q4;42;118;424;748;244;424;0.69;6.34;Switzerland;Western Europe;S. Karger AG;1974-2000;"Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Public Health, Environmental and Occupational Health (Q3); Drug Discovery (Q4)"
277;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.243;Q3;58;23;139;663;53;138;0.31;28.83;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology and Allergy (Q3); Pharmacology (Q3); Immunology (Q4)"
278;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.242;Q2;31;17;65;443;49;64;0.52;26.06;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
279;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.242;Q3;76;63;184;2007;98;171;0.37;31.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
280;130063;Pharmacological Reports;journal;17341140;0.241;Q3;87;74;209;2446;119;208;0.52;33.05;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
281;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.238;Q3;17;15;109;256;66;109;0.73;17.07;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q3)
282;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.237;Q2;57;46;219;766;104;209;0.41;16.65;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
283;24659;Comments on Toxicology;journal;08865140;0.237;Q3;12;25;53;400;26;44;0.21;16;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q3)
284;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.237;Q3;35;183;58;7804;20;58;0.34;42.64;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
285;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.236;Q3;48;142;45;8141;25;45;1.17;57.33;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q3); Toxicology (Q3)"
286;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.232;Q3;36;28;74;780;39;72;0.47;27.86;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
287;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.227;Q4;93;115;374;2534;154;374;0.41;22.03;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
288;20051;BioDrugs;journal;11738804, 1179190X;0.226;Q3;71;79;272;5247;182;257;0.65;66.42;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Biotechnology (Q3); Pharmacology (Q3)"
289;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.225;Q3;98;220;446;3264;197;446;0.48;14.84;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
290;20564;Ceska a Slovenska Farmacie;journal;12107816;0.225;Q2;17;57;149;1155;31;149;0.13;20.26;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q2)
291;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.222;Q2;72;85;344;1674;78;341;0.18;19.69;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
292;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.221;Q3;46;47;99;1097;54;98;0.4;23.34;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
293;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.221;Q3;51;70;182;1261;20;182;0.11;18.01;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
294;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.219;Q2;17;18;60;440;13;60;0.17;24.44;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
295;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.218;Q2;45;81;257;1202;57;257;0.26;14.84;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
296;66652;Toxic Substance Mechanisms;journal;10769188;0.218;Q4;12;16;68;646;23;64;0.34;40.38;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2000;"Pollution (Q3); Toxicology (Q4)"
297;19484;Antibiotics and chemotherapy;journal;00664758, 16622863;0.217;Q3;8;0;33;0;16;33;1;0;Switzerland;Western Europe;S. Karger AG;1956, 1964-1965, 1968-1971, 1974-1976, 1978-1983, 1985, 1987-1989, 1991-1992, 1994-1996, 1998, 2000;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
298;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.216;Q3;53;133;346;3252;162;346;0.47;24.45;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
299;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.215;Q4;48;27;125;444;31;113;0.32;16.44;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
300;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.212;Q2;69;69;137;974;56;137;0.27;14.12;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
301;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.211;Q2;14;34;125;734;32;125;0.21;21.59;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
302;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.21;Q3;62;89;187;1708;39;170;0.23;19.19;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
303;21265;Drugs of the Future;journal;03778282;0.209;Q3;45;100;1336;4625;350;1285;0.39;46.25;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
304;22881;Yaoxue Xuebao;journal;05134870;0.209;Q3;34;212;563;2247;109;563;0.16;10.6;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
305;21229;Drug News and Perspectives;journal;02140934;0.208;Q3;51;60;208;2509;93;200;0.45;41.82;Spain;Western Europe;Prous Science;1990-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
306;145693;Canadian Pharmacists Journal;journal;17151635;0.207;Q2;24;107;231;485;23;172;0.06;4.53;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
307;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.207;Q4;47;40;139;1061;75;138;0.55;26.53;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
308;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.206;Q2;19;196;676;1133;61;672;0.09;5.78;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q2)
309;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.205;Q3;13;25;109;681;31;104;0.37;27.24;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
310;130089;Toxin Reviews;journal;15569543, 15569551;0.205;Q4;46;24;93;1269;57;88;0.6;52.88;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
311;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.203;Q3;53;102;273;5395;128;272;0.4;52.89;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
312;20065;BioPharm International;trade journal;1542166X, 19391862;0.201;Q3;29;103;193;843;53;171;0.27;8.18;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
313;63556;Pharmacie Hospitaliere Francaise;journal;03699579;0.2;Q3;4;92;99;381;18;96;0.17;4.14;France;Western Europe;Syndicat des Pharmaciens Gerants;1982-2000;Pharmaceutical Science (Q3)
314;16893;Biogenic Amines;journal;15693910, 01688561;0.199;Q3;15;30;134;1214;62;133;0.42;40.47;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Pharmacology (Q3); Neuroscience (miscellaneous) (Q4)"
315;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.199;Q3;67;110;299;624;116;270;0.42;5.67;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacy (Q1); Pharmacology (nursing) (Q2); Pharmacology (Q3)"
316;21496;Revista de Chimie (discontinued);journal;00347752;0.199;-;31;118;441;1234;42;441;0.13;10.46;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
317;24097;Journal of the Indian Chemical Society;journal;00194522;0.198;Q4;33;185;644;3194;137;644;0.22;17.26;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
318;40278;Adverse Drug Reactions and Toxicological Reviews;journal;0964198X;0.197;Q3;24;15;51;919;35;40;0.79;61.27;United Kingdom;Western Europe;Adis International Ltd;1991-2002;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
319;89856;In Vitro Toxicology: Journal of Molecular and Cellular Toxicology;journal;0888319X;0.197;Q4;1;0;8;0;1;3;0;0;United States;Northern America;Mary Ann Liebert Inc.;1993-1997;Toxicology (Q4)
320;130031;Journal of Toxicologic Pathology;journal;09149198;0.196;Q4;30;29;86;749;31;86;0.37;25.83;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
321;81781;Pharmaceutical Science and Technology Today;journal;14615347;0.196;Q3;54;96;79;2285;36;77;0.46;23.8;Netherlands;Western Europe;Elsevier BV;1998-2000;Pharmaceutical Science (Q3)
322;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.194;Q3;39;39;134;822;58;134;0.29;21.08;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
323;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.194;Q3;78;46;214;1005;85;212;0.7;21.85;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Medicine (miscellaneous) (Q2); Dermatology (Q3); Pharmacology (Q3); Physiology (Q4)"
324;26370;Molecules;journal;14203049;0.193;Q3;171;70;172;841;57;170;0.31;12.01;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Medicine (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
325;22411;Inflammopharmacology;journal;09254692, 15685608;0.191;Q3;55;34;97;968;54;97;0.52;28.47;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
326;21100829249;Biotherapy;journal;15738280, 0921299X;0.189;Q3;21;0;119;0;65;117;0.64;0;Switzerland;Western Europe;Springer International Publishing AG;1988-1994, 1996-1998;Pharmacology (Q3)
327;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.189;Q3;6;21;80;374;12;80;0.22;17.81;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
328;21867;Geneesmiddelenbulletin;journal;03044629;0.187;Q3;7;87;280;629;12;43;0.04;7.23;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
329;22979;Journal of Applied Therapeutic Research;journal;10292659;0.184;Q3;8;20;23;359;5;23;0.22;17.95;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q3)
330;37381;In Vitro and Molecular Toxicology: Journal of Basic and Applied Research;journal;10979336;0.181;Q4;21;25;128;711;56;125;0.44;28.44;United States;Northern America;Mary Ann Liebert Inc.;1996-2001;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
331;25253;Blutalkohol (discontinued);journal;00065250;0.178;Q4;13;28;92;653;27;90;0.4;23.32;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q4)"
332;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.177;Q3;53;90;248;1741;60;211;0.23;19.34;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
333;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.176;Q3;46;31;146;544;50;146;0.19;17.55;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q3)
334;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.171;Q3;10;43;103;835;17;103;0.19;19.42;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
335;20578;Journal of Food and Drug Analysis;journal;10219498;0.17;Q3;63;33;118;678;16;118;0.13;20.55;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Pharmacology (Q3); Food Science (Q4)"
336;55802;Journal of Pharmaceutical Medicine;journal;09580581;0.167;Q3;4;0;12;0;8;12;0;0;United Kingdom;Western Europe;Adis International Ltd;1991-1996;Pharmacology (Q3)
337;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.166;Q3;36;21;40;472;16;40;0.41;22.48;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
338;13718;Pharmaceutical Engineering;journal;02738139;0.166;Q3;16;42;126;239;14;118;0.1;5.69;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
339;19700180737;Pharmacochemistry Library;journal;01657208;0.165;Q3;10;0;185;0;43;130;0.18;0;Netherlands;Western Europe;Elsevier;1995-1998, 2000, 2002;"Pharmacology (Q3); Drug Discovery (Q4); Organic Chemistry (Q4)"
340;21127;Pharmaceutical Technology Europe;journal;01646826;0.164;Q3;18;91;39;400;6;36;0.15;4.4;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
341;25197;Revista de Toxicologia (discontinued);journal;02127113;0.162;Q4;11;6;44;197;9;44;0;32.83;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
342;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.161;Q4;53;55;322;1113;55;320;0.18;20.24;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q4)"
343;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.159;Q3;60;35;115;749;21;115;0.19;21.4;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
344;22338;Hospital Pharmacy;journal;19451253, 00185787;0.159;Q3;24;158;478;1773;72;399;0.18;11.22;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
345;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.158;Q3;7;6;19;256;8;19;0.58;42.67;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
346;101310;Journal of Applied Therapeutics;journal;10721754;0.158;Q3;6;0;44;0;12;44;0.18;0;Switzerland;Western Europe;Harwood Academic Publishers;1996-1997;Pharmacology (Q3)
347;91481;Pharmacology Reviews and Communications;journal;10288945;0.158;Q3;9;22;102;559;32;102;0.43;25.41;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2002;Pharmacology (Q3)
348;22977;Journal de Pharmacie de Belgique;journal;00472166;0.156;Q3;12;28;454;220;35;451;0.07;7.86;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
349;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.156;Q4;14;18;65;35;12;65;0.19;1.94;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
350;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.155;Q3;63;53;227;1371;65;219;0.34;25.87;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
351;91553;Anaesthetic Pharmacology and Physiology Review;journal;13622013;0.155;Q3;3;0;10;0;3;10;0;0;United Kingdom;Western Europe;Castle House Publications;1996;"Anesthesiology and Pain Medicine (Q3); Pharmacology (Q3)"
352;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.154;Q3;15;16;22;449;8;22;0;28.06;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q3); Physiology (Q4)"
353;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.153;Q3;81;16;19;126;2;16;0.11;7.88;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
354;21813;Research Communications in Alcohol and Substances of Abuse;journal;10808388;0.152;Q4;5;12;41;306;9;41;0.36;25.5;United States;Northern America;PJD Publications Ltd;1994-1999, 2001;"Medicine (miscellaneous) (Q2); Toxicology (Q4)"
355;19700175108;Drug Delivery System;journal;18812732, 09135006;0.151;Q3;8;44;118;703;22;118;0.26;15.98;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q3)
356;21758;Prescrire International;journal;11677422;0.151;Q3;13;87;239;1457;38;221;0.19;16.75;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
357;66831;Proceedings of the Controlled Release Society;journal;10220178;0.151;Q3;14;596;1501;2357;241;1501;0.18;3.95;United States;Northern America;Controlled Release Society, Inc.;1993-1999;Pharmaceutical Science (Q3)
358;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.15;Q3;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3); Clinical Psychology (Q4); Psychiatry and Mental Health (Q4)"
359;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.149;Q4;62;64;235;2114;62;229;0.34;33.03;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q4)
360;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.149;Q3;6;18;32;529;10;32;0;29.39;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q3); Pharmacology (Q3)"
361;38938;Japanese Journal of Toxicology and Environmental Health;journal;0013273X;0.148;Q4;12;17;277;476;57;276;0.21;28;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-1961, 1963-1999;Toxicology (Q4)
362;58672;Prescribers' Journal;journal;00327611;0.146;Q3;6;44;115;359;16;86;0.15;8.16;United Kingdom;Western Europe;Her Majesty's Stationery Office;1970, 1973-2000;Pharmaceutical Science (Q3)
363;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.146;Q3;43;75;220;2560;68;219;0.24;34.13;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
364;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.145;Q3;43;41;52;1213;6;52;0;29.59;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
365;71935;Drug Stability;journal;13555618;0.145;Q3;6;0;30;0;8;30;0;0;United Kingdom;Western Europe;Stockton Press;1996-1997;Pharmaceutical Science (Q3)
366;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.142;Q3;2;2;7;106;1;7;0.25;53;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q3)
367;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.142;Q3;19;75;104;855;20;89;0.19;11.4;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
368;22934;Chinese Pharmaceutical Journal;journal;10012494;0.141;Q3;21;280;626;2254;57;624;0.07;8.05;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
369;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.141;Q3;5;23;48;1457;4;46;0.11;63.35;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Pharmacology (Q3); Immunology (Q4)"
370;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.14;Q4;32;87;112;481;23;50;0.32;5.53;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q4)"
371;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.14;Q3;24;119;347;803;46;346;0.14;6.75;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
372;21142;Pharmaceutisch Weekblad;journal;00316911;0.139;Q3;9;587;1640;2948;110;1453;0.08;5.02;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
373;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.138;Q3;9;0;71;0;16;68;0.15;0;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q3)
374;52550;Pharmacology and Toxicology, Supplement;journal;09019936;0.138;Q3;7;1;40;389;16;40;0.4;389;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1990-2000;"Pharmacology (Q3); Toxicology (Q4)"
375;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.135;Q4;13;51;107;827;16;91;0.09;16.22;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
376;22205;Saudi Pharmaceutical Journal;journal;13190164;0.132;Q3;57;27;96;989;15;88;0.2;36.63;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
377;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.132;Q3;46;266;882;3487;195;880;0.19;13.11;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4)"
378;21837;Revista Portuguesa de Farmacia;journal;0484811X;0.131;Q3;5;21;69;878;9;69;0.13;41.81;Portugal;Western Europe;Ordem dos Farmaceuticos;1961, 1990-2001;Pharmaceutical Science (Q3)
379;79249;Modern Drug Discovery;journal;10998209;0.13;Q3;9;17;6;21;2;6;0.33;1.24;United States;Northern America;American Chemical Society;1998-2001;Pharmaceutical Science (Q3)
380;23171;Korean Journal of Pharmacognosy;journal;02533073;0.127;Q3;17;48;120;802;7;120;0.03;16.71;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
381;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.127;Q4;19;10;111;290;11;111;0.1;29;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q4)"
382;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.126;Q3;21;11;28;879;5;26;0.15;79.91;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
383;75669;Regional Cancer Treatment;journal;09350411;0.126;Q4;5;0;46;0;7;46;0;0;Germany;Western Europe;Springer Verlag;1990-1996;"Oncology (Q4); Pharmacology (Q4)"
384;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.125;Q4;19;126;323;3139;36;323;0.12;24.91;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
385;23009;Journal of Clinical Research;journal;13695207;0.125;Q4;11;14;36;341;13;36;0.36;24.36;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
386;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.125;Q3;13;35;178;504;17;88;0.08;14.4;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
387;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.124;Q4;19;0;70;0;16;70;0.24;0;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q4)"
388;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.124;Q3;8;0;27;0;4;24;0;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4)"
389;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.124;Q4;14;24;45;313;2;45;0.07;13.04;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
390;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;0.123;Q4;94;40;118;4160;9;116;0.08;104;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
391;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.122;Q4;7;162;496;495;8;496;0.02;3.06;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
392;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.122;Q4;29;10;127;192;19;125;0.09;19.2;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
393;35190;Revista Espanola de Quimioterapia;journal;02143429;0.122;Q4;26;49;128;1786;16;112;0.15;36.45;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q4)"
394;22358;U.S. Pharmacist;trade journal;01484818;0.122;Q3;9;0;41;0;2;27;0;0;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
395;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.121;Q3;27;0;1;0;0;1;0;0;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
396;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.121;Q3;42;33;18;378;3;18;0.17;11.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4); Pharmacology (Q4)"
397;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.121;Q4;94;53;1;1572;0;1;0;29.66;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q4); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
398;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.121;Q3;47;0;1;0;0;1;0;0;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
399;23277;Acta Physiologica Pharmacologica et Therapeutica Latinoamericana;journal;03276309;0.12;Q4;13;38;86;402;21;85;0.19;10.58;Argentina;Latin America;Association Latinoamericana de Ciencias Fisiologicas;1991-1999;"Pharmacology (Q4); Physiology (Q4)"
400;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.118;Q4;37;32;89;879;7;85;0.07;27.47;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
401;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.117;Q3;27;58;138;1422;29;136;0.22;24.52;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
402;69108;Chemotherapie Journal, Supplement;journal;09446486;0.117;Q4;6;11;62;156;11;61;0.2;14.18;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
403;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.116;Q4;33;73;178;2422;15;178;0.08;33.18;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
404;21826;Revista Brasileira de Farmacia;journal;0370372X;0.116;Q4;9;25;99;388;3;99;0.02;15.52;Brazil;Latin America;Associacao Brasileira De Farmaceuticos;1945, 1984-2000;Pharmaceutical Science (Q4)
405;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.115;Q4;11;0;97;0;8;96;0.03;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
406;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.115;Q4;2;6;3;46;0;0;0;7.67;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
407;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.114;Q4;9;25;47;505;2;44;0.04;20.2;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
408;21798;Farmaceutski Glasnik;journal;00148202;0.113;Q4;6;44;74;192;2;74;0.03;4.36;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
409;21716;Pharmazeutische Zeitung;journal;00317136;0.113;Q4;7;674;1844;2042;32;1337;0.02;3.03;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
410;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.112;Q4;10;15;39;682;2;39;0.08;45.47;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
411;18800156720;Dissolution Technologies;journal;1521298X;0.112;Q4;34;17;37;62;9;29;0.12;3.65;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q4)
412;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.112;Q4;7;25;93;596;4;93;0.06;23.84;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q4)
413;13637;Manufacturing Chemist;trade journal;02624230;0.112;Q4;6;157;220;252;7;95;0.03;1.61;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
414;79257;Antiinfective Drugs and Chemotherapy;journal;09464832;0.111;Q4;6;0;77;0;13;68;0.18;0;Germany;Western Europe;Futuramed Publishers Gmbh;1994-1998, 2000;Pharmacology (Q4)
415;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.111;Q4;15;159;480;2528;24;480;0.05;15.9;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Toxicology (Q4)"
416;22457;International Pharmacy Journal;journal;10100423;0.111;Q4;4;70;140;159;10;119;0.06;2.27;Netherlands;Western Europe;International Pharamaceutical Federation/Federation Internationale Pharmaceutique;1987-1999;Pharmaceutical Science (Q4)
417;95578;Korean Journal of Pharmacology;journal;03779459;0.111;Q4;1;0;43;0;3;43;0;0;South Korea;Asiatic Region;Eui-Hak Publishing and Printing Co.;1977-1996;Pharmacology (Q4)
418;20543;Pharmacometrics;journal;03008533;0.111;Q4;6;12;185;150;4;185;0.02;12.5;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
419;94058;Comptes Rendus de Therapeutique et de Pharmacologie Clinique;journal;02939908;0.11;Q4;0;0;2;0;0;2;0;0;France;Western Europe;Editions Marc Bancquart;1983-1996;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
420;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.11;Q4;87;0;3;0;2;3;0;0;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
421;20572;PZ Prisma;journal;09455566;0.11;Q4;5;34;87;860;7;86;0.07;25.29;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
422;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.109;Q4;16;327;1142;3732;52;1140;0.04;11.41;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
423;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.109;Q4;7;20;41;465;10;41;0.24;23.25;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
424;74999;American Druggist;journal;01905279;0.108;Q4;3;48;128;255;6;99;0.02;5.31;United States;Northern America;Hearst Corp;1946-1949, 1983-1999;Pharmaceutical Science (Q4)
425;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.108;Q4;35;119;221;1665;6;168;0.02;13.99;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
426;23169;Klinische Pharmakologie Aktuell;journal;09395164;0.108;Q4;3;15;46;40;3;40;0.06;2.67;Germany;Western Europe;W.Zuckschwerdt Verlag GmbH;1995-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
427;68034;Pharmaceutical Medicine;journal;02650673;0.108;Q4;3;0;12;0;3;10;0;0;United Kingdom;Western Europe;Adis International Ltd;1984-1996;Pharmacology (Q4)
428;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.108;Q4;32;148;534;645;19;534;0.02;4.36;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
429;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.107;Q4;12;79;228;852;20;224;0.09;10.78;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
430;21238;Drug Topics;journal;19378157, 00126616;0.107;Q4;8;502;1320;35;28;910;0.02;0.07;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
431;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.106;Q4;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
432;97159;Journal of Research in Pharmaceutical Economics;journal;08966621;0.106;Q4;5;0;70;0;5;70;0.03;0;United States;Northern America;Pharmaceutical Products Press;1996-1998, 2000-2001;"Health Policy (Q4); Pharmaceutical Science (Q4)"
433;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.105;Q4;10;0;12;0;0;9;0;0;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
434;59522;Current Therapeutics;journal;0311905X;0.104;Q4;5;63;145;640;6;145;0.02;10.16;Australia;Pacific Region;ADIS Press;1974-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
435;22514;Japanese Journal of Chemotherapy;journal;13407007;0.104;Q4;12;105;327;2032;9;327;0.05;19.35;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
436;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.103;Q4;4;115;204;919;5;204;0.02;7.99;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
437;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.103;Q4;8;12;53;149;5;53;0.1;12.42;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
438;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.103;-;31;11;32;224;2;28;0.04;20.36;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
439;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.103;Q4;18;14;12;826;1;12;0.11;59;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
440;20134;Therapiewoche;journal;00405973;0.103;Q4;4;0;246;0;3;143;0;0;Germany;Western Europe;G Braun Buchverlag;1961-1965, 1973-1987, 1990-1996;Pharmacology (Q4)
441;52919;British journal of clinical practice. Supplement;journal;02628767;0.102;Q4;1;0;6;0;0;6;0;0;United Kingdom;Western Europe;Medicom International, Inc.;1980, 1984-1991, 1994-1997;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
442;72763;Drugs Made in Germany;journal;00126683;0.102;Q4;4;16;62;180;5;50;0;11.25;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1964, 1973-2002;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
443;22354;IDMA Bulletin;journal;09706054;0.102;Q4;1;0;47;0;1;14;0.02;0;India;Asiatic Region;Indian Drug Manufacturers' Association;1997-1999;"Health Policy (Q4); Pharmacology (Q4)"
444;88338;Journal of Pharmacoepidemiology;journal;08966966;0.102;Q4;4;7;13;70;0;11;0;10;United States;Northern America;"John Wiley &amp; Sons Inc.";1991, 1994-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
445;21823;Pharmacia;journal;04280296;0.102;Q4;16;25;51;323;3;51;0.06;12.92;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
446;60295;Acta Technologiae et Legis Medicamenti;journal;11212098;0.101;Q4;5;10;57;206;2;57;0.07;20.6;Italy;Western Europe;Maccari Editore Srl;1995-1999;Pharmaceutical Science (Q4)
447;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.101;Q4;11;10;20;299;0;20;0;29.9;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
448;22908;Chinese Pharmacological Bulletin;journal;10011978;0.101;Q4;17;185;350;2044;11;350;0.03;11.05;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
449;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.101;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
450;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;9;7;28;119;0;27;0;17;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
451;67942;Lyon Pharmaceutique;journal;00247804;0.101;Q4;3;0;113;0;4;109;0.04;0;France;Western Europe;Association des Pharmaciens - Anciens Eleves - Amis de la Faculte de Pharmacie de Lyon;1961, 1975, 1984, 1993-1998;Pharmaceutical Science (Q4)
452;21077;Pharmaca;journal;00316857;0.101;Q4;5;10;31;355;0;31;0;35.5;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
453;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.101;Q4;34;176;514;3386;6;514;0.01;19.24;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
454;17716;Quality Assurance Journal;journal;10991786, 10878378;0.101;Q4;9;0;22;0;0;22;0;0;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
455;5800207507;Side Effects of Drugs Annual;book series;03786080;0.101;Q4;6;51;102;3092;2;102;0.02;60.63;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
456;20133;Therapie und Erfolg;journal;1433111X;0.101;Q4;1;0;42;0;0;31;0;0;Germany;Western Europe;G Braun Buchverlag;1998;Pharmacology (Q4)
457;19408;Actualites Pharmaceutiques;journal;05153700;0.1;Q4;5;56;102;543;0;102;0;9.7;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
458;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.1;Q4;6;35;152;955;1;152;0.01;27.29;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
459;54564;Antimicrobics and Infectious Diseases Newsletter;journal;1069417X;0.1;Q4;5;0;49;0;1;47;0.02;0;Netherlands;Western Europe;Elsevier BV;1994-1998, 2000, 2002;"Microbiology (medical) (Q4); Pharmacology (Q4)"
460;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.1;Q4;20;20;109;59;2;109;0;2.95;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
461;22887;Chinese Journal of Antibiotics;journal;10018689;0.1;Q4;11;149;330;998;2;318;0;6.7;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
462;35042;Ciencia Pharmaceutica;journal;11315253;0.1;Q4;2;0;37;0;2;36;0.09;0;Spain;Western Europe;Alpe Editores;1991-1998;Pharmacology (Q4)
463;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;53;115;166;0;101;0;3.13;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
464;19900191748;Clin-Alert;journal;1530812X, 00694770;0.1;Q4;0;0;69;0;0;69;0;0;United States;Northern America;Science Editors;1996-1998;"Pharmacology (Q4); Toxicology (Q4)"
465;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;5;8;44;607;0;44;0;75.88;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
466;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;18;52;239;0;52;0;13.28;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
467;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.1;Q4;24;54;175;1241;8;145;0.03;22.98;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
468;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;15;70;417;0;70;0;27.8;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
469;37682;Gyogyszereszet;journal;00176036;0.1;Q4;2;20;81;371;1;81;0;18.55;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1960-1962, 1973-1985, 1988-2000;Pharmacology (Q4)
470;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.1;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
471;83985;Indian Journal of Indigenous Medicines;journal;09715452;0.1;Q4;4;0;51;0;8;50;0.04;0;India;Asiatic Region;Society of Phytomedica;1996-1997;Pharmacology (Q4)
472;76262;Journal of Venomous Animals and Toxins;journal;01047930;0.1;Q4;0;0;0;0;0;0;0;0;Brazil;Latin America;Centro de Estudos de Venenos e Animais Peconhentos;1996-1998;Toxicology (Q4)
473;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.1;Q4;5;21;73;390;0;73;0;18.57;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
474;63560;Pharmaceutical Visions;journal;09661719;0.1;Q4;1;57;86;76;0;35;0;1.33;United Kingdom;Western Europe;London Monarch Communications;1997-2001;Pharmaceutical Science (Q4)
475;21227;Pharmacy in Practice;journal;13581538;0.1;Q4;5;18;98;72;3;55;0.03;4;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
476;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.1;Q4;9;21;49;315;0;49;0;15;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
477;11000153745;Schweizer Apothekerzeitung;journal;14204932;0.1;Q4;1;0;38;0;0;35;0;0;Switzerland;Western Europe;SAV, Schweizerischer Apothekerverein;1994-1997;Pharmaceutical Science (Q4)
478;36238;Therapiewoche Schweiz;journal;02566869;0.1;Q4;1;31;127;72;0;92;0;2.32;Switzerland;Western Europe;Therapiewoche Verlag;1990-2000;Pharmacology (Q4)
479;4000148019;AAPS Journal;journal;15507416;;-;118;34;0;802;0;0;0;23.59;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science
480;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;;-;20;35;89;702;8;89;0.12;20.06;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science
481;19407;Acta Poloniae Toxicologica;journal;12306967;;-;4;26;0;488;0;0;0;18.77;Poland;Eastern Europe;Polskie Towarzystwo Toksykologiczne/Polish Society of Toxicology;1999-2002;Toxicology
482;20680;Current Opinion in Molecular Therapeutics;journal;14648431;;-;66;93;0;5163;0;0;0;55.52;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery; Genetics; Genetics (clinical); Molecular Biology; Molecular Medicine; Pharmacology"
483;21264;Drugs in R and D;journal;11796901, 11745886;;-;47;240;0;1216;0;0;0;5.07;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology
484;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;14;41;306;28;41;0.5;21.86;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
485;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;;-;83;16;0;861;0;0;0;53.81;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous); Pharmacology; Pharmacology (medical)"
486;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;;-;18;27;0;995;0;0;0;36.85;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science
487;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;;-;9;12;0;153;0;0;0;12.75;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine; Toxicology"
488;35452;Journal of Autonomic Pharmacology;journal;01441795;;-;26;48;147;1511;176;147;0.71;31.48;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1980-2001;"Neuroscience (miscellaneous); Pharmacology"
489;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;37;50;332;0;50;0;8.97;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
490;25144;Journal of Health Science;journal;13475207, 13449702;;-;49;103;0;1500;0;0;0;14.56;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis; Toxicology"
491;21281;Journal of Immunotherapy;journal;10538550;;-;46;12;55;395;226;55;3.9;32.92;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2004;"Cancer Research; Immunology; Pharmacology"
492;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;43;78;805;8;77;0.1;18.72;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
493;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;44;103;1161;18;103;0.17;26.39;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
494;18071;Neurotoxicity Research;journal;14763524, 10298428;;-;78;1;0;116;0;0;0;116;United States;Northern America;Springer New York;1999, 2001-2021;"Neuroscience (miscellaneous); Toxicology"
495;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;;-;10;17;0;266;0;0;0;15.65;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
496;72755;Phytomedica;journal;09723293;;-;4;13;0;162;0;0;0;12.46;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine; Pharmacology"
497;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;;-;29;9;0;136;0;0;0;15.11;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine; Pharmacology"
498;34348;Teratogenesis Carcinogenesis and Mutagenesis;journal;02703211;;-;40;38;87;1266;104;86;1.26;33.32;United States;Northern America;"John Wiley &amp; Sons Inc.";1980-2003;"Genetics; Genetics (clinical); Health, Toxicology and Mutagenesis; Oncology; Toxicology"
499;38272;Teratology;journal;00403709;;-;73;115;211;3452;316;197;1.38;30.02;United States;Northern America;"John Wiley &amp; Sons Inc.";1968-2002;"Developmental Biology; Embryology; Health, Toxicology and Mutagenesis; Toxicology"
